MV BioTherapeutics ApyraMed

ATP Bacteria Altered intestinal homeostasis Antibiotics administration ApyraMed mechanism Inflammation / susceptibility
to infection Secretory IgA Normal intestinal homeostasis​ Loss of intestinal integrity ApyraMed administration
and Apyrase mediated
ATP degradation Back to Normal intestinal homeostasis Preservation of gut barrier
integrity and intestinal function

Technology

The ApyraMed technology exploits regulated delivery of recombinant apyrase to promote adaptive intestinal homeostasis. In cancer patients, it enhances immune system competence, whereas in dysbiosis safeguards the intestinal ecosystem.

MV BioTherapeutics ApyraMed